Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline
- MeSH Terms
- Bone Density Conservation Agents (D27.505.696.242); Prostatic Neoplasms (C04.588.945.440.770)
- Guideline Contact
- guidelines@asco.org
- Publication Date
- 28-Jan-20
- Publication Scope
- management
- Countries of Application
- United States
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- ASCO (US)
- Publication Year
- 2020